Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

Subtypes of Breast Cancer

In: Breast Cancer [Internet]. Brisbane (AU): Exon Publications; 2022 Aug 6. Chapter 3.
Affiliations
Free Books & Documents
Review

Subtypes of Breast Cancer

Erasmo Orrantia-Borunda et al.
Free Books & Documents

Excerpt

Breast cancer is a genetically and clinically heterogeneous disease with multiple subtypes. The classification of these subtypes has evolved over the years. The most common and widely accepted classification of breast cancer is from an immunohistochemical perspective, based on the expression of the following hormone receptors: estrogen (ER), progesterone (PR) and human epidermal growth factor (HER2). Accordingly, the following four subtypes of breast cancer are widely recognized: luminal A, luminal B, HER2-positive, and triple-negative. With the recent advances in cancer research, and an increased molecular understanding of breast cancer, the current clinical model for classification of breast cancer may be benefit from the addition of several molecular markers such as miRNAs (let-7, miR-155, miR-150, miR-153) and mutations (p53, BRCA 1 and 2 genes). This chapter provides an overview of the characteristics of these four subtypes of breast cancer.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: The authors declare no potential conflicts of interest with respect to research, authorship and/or publication of this manuscript.

References

    1. Shaath H, Elango R, Alajez NM. Molecular Classification of Breast Cancer Utilizing Long Non-Coding RNA (lncRNA) Transcriptomes Identifies Novel Diagnostic lncRNA Panel for Triple-Negative Breast Cancer. Cancers. 2021;13(21):5350. https://doi.org/10.3390/cancers13215350 . - DOI - PMC - PubMed
    1. Zhang MH, Man HT, Zhao XD, Dong N, Ma SL. Estrogen receptor-positive breast cancer molecular signatures and therapeutic potentials (Review) Biomed Rep. 2013;2:41–52. https://doi.org/10.3892/br.2013.187 . - DOI - PMC - PubMed
    1. Miah S, Bagu E, Goel R, Ogunbolude, Dai C, Ward A, et al. Estrogen receptor signaling regulates the expression of the breast tumor kinase in breast cancer cells. BMC Cancer. 2019;19:78. https://doi.org/10.1186/s12885-018-5186-8 . - DOI - PMC - PubMed
    1. Hicks DG, Lester SC. Hormone Receptors (ER/PR) Diagn Pathol. 2016:430–439. https://doi.org/10.1016/B978-0-323-37712-6.50067-3 . - DOI
    1. Nicolini A, Ferrari P, Duffy MJ. Prognostic and predictive biomarkers in breast cancer: Past, present and future. Semin Cancer Biol. 2018;52(1):56–73. https://doi.org/10.1016/j.semcancer.2017.08.010 . - DOI - PubMed

LinkOut - more resources